Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

TSHA-104 AAV9 gene-replacement therapy for Leigh syndrome shows promising results

Sep. 20, 2021

Targeting GCN2 or elevating tRNAGly levels may be useful in Charcot-Marie-Tooth disease

Sep. 20, 2021

VU-6028418 reverses cataleptic behavior in rat models

Sep. 17, 2021

Guanylate cyclase C agonist IW-3300 shows promise for treating visceral pain

Sep. 17, 2021

Mitokinin discloses PINK1 activators

Sep. 17, 2021

Blood-to-brain pathway may deliver amyloids in Alzheimer's disease

Sep. 16, 2021

Discovery of OXS-00005, a small-molecule candidate for regenerative medicine

Sep. 16, 2021

Base excision repairing may modulate susceptibility to Parkinson's disease

Sep. 16, 2021

HTL-0041178 shows efficacy in models of psychosis and cognitive impairment

Sep. 16, 2021

Mindset Pharma shows MSP-1014 is comparable to psilocybin in drug discrimination assay

Sep. 15, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...